Solid Growth Forecast for Intracranial Aneurysm Market

The global intracranial aneurysm market is set to expand 8.8 % annually over the next decade to reach $2.56 billion in 2032. The sector’s expansion is expected to be fueled by rising numbers of brain aneurysms, technological advancements, and new minimally invasive surgeries, according to Future Market Inisights. 
 
Intracranial brain aneurysms occur when an artery in the brain bulges, causing swelling, ballooning, and widening. Aneurysms weaken the walls and make it hard for the nerves to function properly. The intracranial aneurysm market size can be attributed to new advanced technology integrating with intracranial aneurysm treatment and solutions. As the risk of walls bursting increases, end user patients and treatment centers adopt the intracranial aneurysm treatment and solution methods.  

Minimally invasive techniques go through a catheter to locate the aneurysm in the brain. Growing hypertension among the planet’s geriatric population increases the risk of developing brain aneurysms and other diseases.
 
The market consists of three major segments—surgical clipping, endovascular coiling, and flow diverters. The endovascular coiling segment dominates the market, comprising 85.3% of the global share.

The end user category is dominated by the hospital segment, capturing 89.5% of the global market. The segment will grow 8.9% annually through 2032, thanks to the application of technologically advanced tools in operation theaters and intensive care units along with increased number of healthcare units, Future Market Insights predicts. 

North America holds 27% of the global share due to the number of healthcare facilities, government investments, and rising cases of brain aneurysms. The Asia Pacific region is anticipated to thrive at the highest annual growth—12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.
 
“The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the internet of things (IOT) are integrating with the treatment solutions. Countries such as the U.S., the U.K., and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the U.S. develop an unruptured intracranial aneurysm. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions,” a Future Market Insights analyst stated.
 
The Intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market. 
 
The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic plc, Microport Scientific Corporation, B. Braun, Stryker Corporation, Johnson and Johnson Services Inc., Microvention Inc., and Codman Neuro (Integra Lifesciences).
  
MicroPort Scientific Corporation has introduced new therapies for neurovascular intervention that resolve potential issues related to brain aneurysms, offering specific tools to surgeons. This fuels the sales of intracranial aneurysm treatment solutions. 

Stryker has added the neuroform atlas stent system that is further used in conjunction with metal coils that help in packing Aneurysms (weak walls and blood vessel scar) in the brain. This is anticipated to help multiple surgeons worldwide.